What is Harm Reduction Coalition?
Harm Reduction Coalition operates as a national advocacy and capacity-building entity dedicated to the health and dignity of individuals affected by drug use. The organization serves as a vital bridge between grassroots community needs and high-level public policy dialogue. By focusing on harm reduction practices, the company addresses the intersection of addiction, incarceration, and social injustice. Its market position is defined by its unique ability to influence policy while simultaneously providing the infrastructure necessary for local programs to thrive. The coalition's work is essential in upholding the right to health for vulnerable populations, ensuring that those most impacted by drug-related harm have a seat at the table in shaping national health strategies.
How much funding has Harm Reduction Coalition raised?
Harm Reduction Coalition has raised a total of $1.1M across 2 funding rounds:
Unspecified
$750K
Debt
$350K
Unspecified (2019): $750K with participation from CVS Health
Debt (2020): $350K led by PPP
Key Investors in Harm Reduction Coalition
CVS Health
CVS Health is a leading healthcare innovation company that focuses on delivering superior, connected experiences to improve the health and well-being of consumers through its extensive network of pharmacies and clinics.
PPP
Public-Private Partnership
What's next for Harm Reduction Coalition?
With the recent infusion of capital, the Harm Reduction Coalition is expected to accelerate its strategic initiatives aimed at expanding its national footprint and deepening its policy influence. The organization will likely prioritize the scaling of its capacity-building programs, which provide the necessary tools for local health advocates to implement evidence-based harm reduction strategies. Furthermore, the coalition is poised to intensify its efforts in addressing the social determinants of health, specifically targeting the systemic inequalities that exacerbate drug-related crises. As the organization moves into this next phase of growth, it will likely focus on strengthening its partnerships with healthcare providers and public policy stakeholders to ensure that harm reduction remains a central pillar of the national health agenda. This strategic deployment of resources will be critical in navigating the evolving landscape of addiction services and public health policy.
See full Harm Reduction Coalition company page
